Catharine Wang, PhD

Associate Professor, Community Health Sciences
Catharine Wang
(617) 638-5187clwang@bu.edu
Crosstown Center – CT451
View full profile at BUMC

Biography

Dr. Wang is an Associate Professor in the Community Health Sciences Department, and a Peter T. Paul Career Development Professor, at Boston University. She obtained her doctorate in Health Behavior and Health Education from the University of Michigan. Dr. Wang’s research interests are in the areas of public health genomics, health communication, health literacy, and cancer prevention and control. She currently serves as a member of the National Cancer Institute’s PDQ Cancer Genetics Editorial Board. Dr. Wang’s ongoing research is funded by the National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI). One primary research area focuses on examining methods to effectively communicate genetic and environmental risk information for public health promotion and disease prevention. She received funding from NHGRI to examine how communicating genetic risk for obesity might influence efforts to engage in healthy lifestyle behaviors. Dr. Wang is also the Principal Investigator on a NCI-K07 award to examine the impact of genetic and environmental risk information on modifying causal attributions for colorectal cancer, which may subsequently influence relevant cancer screening and lifestyle behaviors. In addition, Dr. Wang is seeking ways to translate genomic discoveries into clinical and public health practice. She is a collaborative investigator on the Family Healthware Impact Trial (FHITr), which sets out to evaluate the clinical utility of a self-administered, web-based tool that assesses familial risk for six common diseases and provides a prevention plan with personalized recommendations for lifestyle changes and screening. Dr. Wang is also conducting research to examine barriers to genetic literacy (i.e., understanding and using family history for public health prevention) among underserved populations. With an R01 grant from NHGRI, she is collaborating with clinicians and computer scientists at Boston Medical Center and Northeastern University to create a “virtual counselor” to ascertain family health history in efforts to overcome previously identified barriers to using computerized tools and facilitate the use of family history a vehicle for personalized medicine.

Education

  • University of Michigan, PhD
  • University of Waterloo , MSc
  • University of Michigan, PhD

Classes Taught

  • SPHSB821

Publications

  • Published on 4/19/2015

    Wang C, Sen A, Plegue M, Ruffin MT, O''Neill SM, Rubinstein WS, Acheson LS. Impact of family history assessment on communication with family members and health care providers: A report from the Family Healthware™ Impact Trial (FHITr). Prev Med. 2015 Aug; 77:28-34.

    Read at: PubMed
  • Published on 1/15/2015

    Wang C, Bickmore T, Bowen DJ, Norkunas T, Campion M, Cabral H, Winter M, Paasche-Orlow M. Acceptability and feasibility of a virtual counselor (VICKY) to collect family health histories. Genet Med. 2015 Jan 15.

    Read at: PubMed
  • Published on 10/23/2014

    Juthe RH, Zaharchuk A, Wang C. Celebrity disclosures and information seeking: the case of Angelina Jolie. Genet Med. 2015 Jul 2; 17(7):545-53.

    Read at: PubMed
  • Published on 11/11/2013

    Wang C, Gordon ES, Stack CB, Liu CT, Norkunas T, Wawak L, Christman MF, Green RC, Bowen DJ. A randomized trial of the clinical utility of genetic testing for obesity: design and implementation considerations. Clin Trials. 2014 Feb; 11(1):102-13.

    Read at: PubMed
  • Published on 10/1/2012

    Wang C, Sen A, Ruffin MT, Nease DE, Gramling R, Acheson LS, O'Neill SM, Rubinstein WS. Family history assessment: impact on disease risk perceptions. Am J Prev Med. 2012 Oct; 43(4):392-8.

    Read at: PubMed
  • Published on 9/1/2012

    Vig HS, Wang C. The evolution of personalized cancer genetic counseling in the era of personalized medicine. Fam Cancer. 2012 Sep; 11(3):539-44.

    Read at: PubMed
  • Published on 1/17/2012

    Dorman JS, Valdez R, Liu T, Wang C, Rubinstein WS, O'Neill SM, Acheson LS, Ruffin MT, Khoury MJ. Health beliefs among individuals at increased familial risk for type 2 diabetes: implications for prevention. Diabetes Res Clin Pract. 2012 May; 96(2):156-62.

    Read at: PubMed
  • Published on 11/1/2011

    Rubinstein WS, Acheson LS, O'Neill SM, Ruffin MT, Wang C, Beaumont JL, Rothrock N. Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med. 2011 Nov; 13(11):956-65.

    Read at: PubMed
  • Published on 1/1/2011

    Ruffin MT, Nease DE, Sen A, Pace WD, Wang C, Acheson LS, Rubinstein WS, O'Neill S, Gramling R. Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med. 2011 Jan-Feb; 9(1):3-11.

    Read at: PubMed
  • Published on 1/1/2011

    Rubinstein WS, O'neill SM, Rothrock N, Starzyk EJ, Beaumont JL, Acheson LS, Wang C, Gramling R, Galliher JM, Ruffin MT. Components of family history associated with women's disease perceptions for cancer: a report from the Family Healthware™ Impact Trial. Genet Med. 2011 Jan; 13(1):52-62.

    Read at: PubMed

View 23 more publications:View full profile at BUMC